Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 12491208.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
One hundred eighty human immunodeficiency virus (HIV)- and hepatitis C virus (HCV)-coinfected patients were prospectively evaluated for suitability for interferon and ribavirin therapy. Of the 149 patients with chronic HCV infection who completed the evaluation, 44 (30%) were eligible for treatment and 105 (70%) were ineligible, with the main barriers being missed clinic visits, active psychiatric illness, active drug or alcohol use, decompensated liver disease, or medical illness.
Medical subject headings
- Antiviral Agents
- HIV Infections
- Hepatitis C
- Interferons